Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering
10 pending office actions • 9 clients • 10 examiners • 9 art units • 0 of 10 (0%) have an AI response strategy ready
BIOTECH BEACH LAW PC has 855 career applications and 10 pending office actions in Biotechnology & Pharmaceuticals. The application history provides meaningful activity context, while the pending docket identifies current matters that remain in prosecution.
The firm reports a resolved allowance rate of 87.52% and an average of 3.16 office actions per allowance. The first measure addresses resolved application outcomes, and the second reflects office-action interaction for allowed matters. Clients can use these figures to frame expectations for both allowance prospects and response effort, then assess the firm’s fit for the particular biological or pharmaceutical subject matter.
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (10%) |
| §103 only | 3 (30%) |
| §102 only | 1 (10%) |
| §112 only | 1 (10%) |
| Multi-statute (no §101) | 4 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HESS, DOUGLAS A | 1 | 88.9% | +10.6% |
| CRAWFORD, GENE O | 1 | 45.9% | +5.7% |
| KASAYAN, KATRIEL BARCELLANO | 1 | 25.0% | +0.0% |
| JALALZADEH ABYANE, SHILA | 1 | 50.6% | +48.8% |
| WESTERBERG, NISSA M | 1 | 23.4% | +37.3% |
| MCWILLIAMS, KELSEY LYNN | 1 | 89.2% | +5.8% |
| KASSA, TIGABU | 1 | 36.7% | +27.9% |
| RIVERA, CARLOS A | 1 | 77.4% | +28.9% |
| BRADLEY, CHRISTINA | 1 | 62.6% | +33.3% |
| GIAMMONA, FRANCESCA FILIPPA | 1 | 37.3% | +58.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19113911 | Crossbelt Sorter | HESS, DOUGLAS A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17827584 | COMPOSITIONS AND METHODS FOR TREATING NERVOUS SYSTEM INJURIES | BRADLEY, CHRISTINA | 103d overdue |
| 18026101 | METHODS FOR THE PRODUCTION OF GENOME EDITED PLANTS | MCWILLIAMS, KELSEY LYNN | 71d overdue |
| 18131841 | PHARMACEUTICAL KITS AND THEIR USE FOR TREATING DRY EYE DISEASE | WESTERBERG, NISSA M | 5d overdue |
| 18705554 | METHOD OF MOUNTING A BIOLOGICAL SAMPLE ON A SURFACE | KASAYAN, KATRIEL BARCELLANO | 33d |
| 18873698 | INTRALOGISTIC CONVEYOR ARRANGEMENT | CRAWFORD, GENE O | — |
| 18008421 | NANOPARTICULATE COMPOSITION | KASSA, TIGABU | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17827584 | COMPOSITIONS AND METHODS FOR TREATING NERVOUS SYSTEM INJURIES | BRADLEY, CHRISTINA | 103d overdue |
| 18550285 | SPORTS APPARATUS | JALALZADEH ABYANE, SHILA | 38d overdue |
| 17801500 | METHOD AND ASSEMBLY FOR POLISHING OPTICAL CABLES | RIVERA, CARLOS A | 30d overdue |
| 18131841 | PHARMACEUTICAL KITS AND THEIR USE FOR TREATING DRY EYE DISEASE | WESTERBERG, NISSA M | 5d overdue |
| 19113911 | Crossbelt Sorter | HESS, DOUGLAS A | — |
| 18008421 | NANOPARTICULATE COMPOSITION | KASSA, TIGABU | — |
| 17413181 | NUCLEIC ACID AMPLIFICATION AND IDENTIFICATION METHOD | GIAMMONA, FRANCESCA FILIPPA | — |
| Client (Assignee) | Pending OAs |
|---|---|
| INTERROLL HOLDING AG | 2 |
| RESOLVE BIOSCIENCES GMBH | 1 |
| BOWNCE HOLDING PLC | 1 |
| SURFACE OPHTHALMICS, INC. | 1 |
| Fraunhofer | 1 |
| Algiax Pharmaceuticals | 1 |
| PRECISION FIBER PRODUCTS, INC. | 1 |
| Sanford Burnham Prebys | 1 |
| Lexogen | 1 |
| Art Unit | Apps |
|---|---|
| 3651 | 2 |
| 1634 | 1 |
| 3784 | 1 |
| 1618 | 1 |
| 1663 | 1 |
| 1619 | 1 |
| 3723 | 1 |
| 1654 | 1 |
| 1681 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19113911 | Crossbelt Sorter | Interroll Holding AG | HESS, DOUGLAS A | 3651 | §102 | Non-Final OA | — | Pending | Mar 21, 2025 |
| 18873698 | INTRALOGISTIC CONVEYOR ARRANGEMENT | Interroll Holding AG | CRAWFORD, GENE O | 3651 | §102§103 | Non-Final OA | — | Pending | Dec 10, 2024 |
| 18705554 | METHOD OF MOUNTING A BIOLOGICAL SAMPLE ON A SURFACE | Resolve Biosciences GmbH | KASAYAN, KATRIEL BARCELLANO | 1634 | §103 | Final Rejection | 33d | Pending | Apr 27, 2024 |
| 18550285 | SPORTS APPARATUS | BOWNCE HOLDING PLC | JALALZADEH ABYANE, SHILA | 3784 | §112 | Non-Final OA | 38d overdue | Pending | Sep 12, 2023 |
| 18131841 | PHARMACEUTICAL KITS AND THEIR USE FOR TREATING DRY EYE DISEASE | Surface Ophthalmics, Inc. | WESTERBERG, NISSA M | 1618 | §103§112Other | Final Rejection | 5d overdue | Pending | Apr 06, 2023 |
| 18026101 | METHODS FOR THE PRODUCTION OF GENOME EDITED PLANTS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | MCWILLIAMS, KELSEY LYNN | 1663 | §103§112 | Non-Final OA | 71d overdue | Pending | Mar 13, 2023 |
| 18008421 | NANOPARTICULATE COMPOSITION | Algiax Pharmaceuticals GmbH | KASSA, TIGABU | 1619 | §103§112 | Final Rejection | — | Pending | Dec 05, 2022 |
| 17801500 | METHOD AND ASSEMBLY FOR POLISHING OPTICAL CABLES | Precision Fiber Products, Inc. | RIVERA, CARLOS A | 3723 | §103 | Final Rejection | 30d overdue | Pending | Aug 22, 2022 |
| 17827584 | COMPOSITIONS AND METHODS FOR TREATING NERVOUS SYSTEM INJURIES | Sanford Burnham Prebys Medical Discovery Institute | BRADLEY, CHRISTINA | 1654 | §101§102§112Other | Non-Final OA | 103d overdue | Pending | May 27, 2022 |
| 17413181 | NUCLEIC ACID AMPLIFICATION AND IDENTIFICATION METHOD | Lexogen GmbH | GIAMMONA, FRANCESCA FILIPPA | 1681 | §103 | Final Rejection | — | Pending | Jun 11, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial87.5% of resolved applications prosecuted by Biotech Beach Law Pc were allowed, across 855 applications in USPTO records.
3.16 office actions per allowed application on average.
10 pending office actions as of October 2026, for 9 clients, before 10 examiners in 9 art units.
